February 23, 2022
Applications Open for TraCS TL1 Postdoc Fellowships
NC TraCS is recruiting candidates for a 1-year postdoctoral fellowship in translational science. Applications accepted on a rolling basis for appointment in 2022.
Category: Clinical Research
February 23, 2022
NC TraCS Institute Now Accepting Applications for ACTeR Program Phase 2
TraCS Team Science supports the formation and development of multidisciplinary research teams tackling challenging problems in clinical or translational medicine.
February 21, 2022
Increasing Accessible Clinical Research Information with Research for Me
Research for Me has added new features for managing potential participant interest, understanding listing metrics, and adding a webpage to highlight available research.
February 21, 2022
New Community and Patient Advisory Board to Guide Equitable Approaches to Clinical and Translational Science at NC TraCS
Last fall the North Carolina Translational and Clinical Sciences Institute launched a new Community and Patient Advisory Board focused on promoting and supporting equity in research. The 11-member board consists of community members, patients and advocates from across North Carolina with varied perspectives, backgrounds and experiences.
February 15, 2022
Phase 3 Study Results Show Positive Data in Treatment of Myasthenia Gravis with Zilucoplan
James F. Howard Jr., MD, professor in the UNC Department of Neurology, was lead investigator in UCB's RAISE trial to evaluate zilucoplan as a treatment for generalized myasthenia gravis in adults.
February 14, 2022
Study Shows Pandemic Has Adversely Affected Clinicians in Safety-Net Practices
Research led by Donald Pathman, MD, MPH, and Jeffrey Sonis, MD, MPH, published in Public Health Reports shows the trauma to healthcare clinicians in low-income communities.
February 10, 2022
The Pandemic’s Impact on Primary Care Practice-Based Research Networks
Drs. Katrina Donahue, Jacquie Halladay, Michelle Hernandez, and colleagues published in Health Affairs using the analogy of a watershed to explain the primary care system and how the pandemic has adversely affected its Practice-Based Research Networks (PBRNs), a vital infrastructure that provides the capacity to assess and improve health outcomes where most people receive care.
February 9, 2022
NC TraCS Pilot Program Update 2022
Funding for the current CTSA grant ends in February 2023. Because we cannot guarantee uninterrupted pilot support until we know that NC TraCS funding is secure, we are suspending the TraCS $2K, $2K Stakeholder Engagement Voucher, FastTraCS, and $5-50K Pilot Programs for the time being.
January 20, 2022
Oral Immunotherapy Alleviates Peanut Allergy in Some Young Children
This study, called IMPACT, was co-led by A. Wesley Burks, MD, CEO of UNC Health and dean of the UNC School of Medicine. Edwin Kim, MD, is co-author on the paper and leads peanut allergy research at the UNC School of Medicine.
January 5, 2022
TraCS Team Science ACTeR Program Now Accepting Submissions for Phase 1 Support
NC TraCS Team Science is seeking to assist UNC researchers with the formation and development of multidisciplinary research teams focused on tackling challenging problems in clinical or translational medicine through our new Advancing Collaborative Team Research (ACTeR) Program. NC TraCS is currently accepting applications for Phase 1 ACTeR applications.
December 29, 2021
Shoenbill, Team Publish Study on Telehealth Benefits in Tobacco Treatment for Inpatient Populations
Kim Shoenbill, MD, PhD, at UNC Family Medicine and colleagues published the study "An Analysis of Inpatient Tobacco Use Treatment Transition to Telehealth" in Nicotine & Tobacco Research. The study provides the first analysis of inpatient tobacco use treatment during the transition to telehealth during the COVID-19 pandemic. It finds that telehealth services for inpatient populations resulted in a larger scope of patients reached and expanded participation in cessation counseling.
December 15, 2021
Reminder: Eshelman Institute Grant Funding Available
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious disease, and neuroscience, including rare diseases, and all digital health technologies. The Institute also welcomes ideas for devices and diagnostics, and other therapeutic areas and services.